USPTO serial 78722164
GENEGLOBE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 25, 2007
- Examiner
- THOMAS JR, RAY
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GENEGLOBE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hilden, DE
40724 Hilden, DE
40724 Hilden, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Victoria Friedman
Victoria Friedman Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of siRNA compounds, protein assays and chemical reagents, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material | ACTIVE | — |
| 005 | Products for human medicine and veterinary medicine purposes, in particular diagnostic preparations, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical biochemical and biotechnological products all for human medicine and veterinary medicine purposes, in particular reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits consisting primarily of siRNA compounds, protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material | ACTIVE | — |
| 009 | [ Scientific apparatuses, instruments and equipment, namely, optical apparatuses and instruments, calculating machines, electrical and electronic apparatuses and instruments, in particular for research and analysis purposes, and laboratory equipment, measuring apparatuses and instruments, namely, robot manipulators, laboratory consumable dispensers, laboratory sample conditioners, namely, incubators, stirrers, mixers, dispensers, aspirators, laboratory and measuring apparatuses and instruments, filter systems for laboratory purposes, ultrafiltration devices and apparatuses, ultrafiltration membranes, chromatography apparatuses and instruments, ion exchanger apparatuses and instruments, laboratory concentrator devices, scientific apparatuses and instruments being laboratory equipment and single-use laboratory articles, in particular laboratory apparatuses for the processing of fluid samples, in particular apparatuses for dosing, transferring, mixing, tempering, concentrating, homogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and the purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research, development and diagnostics in the field of cancer treatment and diagnosis, treatment and diagnosis of viral and bacterial mediated diseases, treatment and diagnosis of diseases of the blood, treatment and diagnosis of diseases of the skin, treatment and diagnosis of diseases of the brain, treatment and diagnosis of diseases of the heart, treatment and diagnosis of diseases of the liver, treatment and diagnosis of diseases of the lungs; as well as design services, namely, work on and evaluation of chemical syntheses, in particular the synthesis of oligonucleotides, polynucleotides and proteins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named GENEGLOBE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 3, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 3, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 3, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 3, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 3, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 21, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 21, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 21, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 21, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 21, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 21, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 15, 2017 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Nov 15, 2017 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Nov 15, 2017 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Nov 7, 2017 | PR89 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | — |
| Oct 25, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 18, 2017 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 18, 2017 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| Sep 4, 2017 | 89AF | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | — |
| Sep 4, 2017 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Sep 25, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 29, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 29, 2013 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 21, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 21, 2013 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| Sep 28, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 24, 2013 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Sep 24, 2013 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 25, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 10, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 7, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 7, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 7, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2007 | PAPER RECEIVED | — | |
| Nov 18, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 12, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2006 | PAPER RECEIVED | — | |
| Apr 10, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2005 | NWAP | NEW APPLICATION ENTERED | — |